HOME >> BIOLOGY >> NEWS
Gene therapy reaches muscles throughout the body and reverses muscular dystrophy in animal model

Researchers have found a delivery method for gene therapy that reaches all the voluntary muscles of a mouse including heart, diaphragm and limbs and reverses the process of muscle-wasting found in muscular dystrophy.

"We have a clear 'proof of principle' that it is possible to deliver new genes body-wide to all the striated muscles of an adult animal. Finding a delivery method for the whole body has been a major obstacle limiting the development of gene therapy for the muscular dystrophies. Our new work identifies for the first time a method where a new dystrophin gene can be delivered, using a safe and simple method, to all of the affected muscles of a mouse with muscular dystrophy," said Dr. Jeffrey S. Chamberlain, professor of neurology and director of the Muscular Dystrophy Cooperative Research Center at the University of Washington School of Medicine in Seattle. He also has joint appointments in the departments of medicine and biochemistry.

Chamberlain is the senior author of the paper describing the results, which will be published in the August edition of Nature Medicine. The paper describes a type of viral vector, a specific type of an adeno-associated virus (AAV), which is able to 'home-in' on muscle cells and does not trigger an immune system response. The delivery system also includes use of a growth factor, VEGF, that appears to increase penetration into muscles of the gene therapy agent. Chamberlain said the formula was the result of about a year of trying different methods.

Duchenne muscular dystrophy is an X-linked genetic disorder that strikes one of every 3,500 newborn boys. The genetic disorder eliminates production of the dystrophin protein, which is necessary for the structural support of muscle. Without this protein, muscles weaken to the point where the victim cannot survive.

"By giving one single injection of this AAV vector carrying
'"/>

Contact: Walter Neary
wneary@u.washington.edu
206-685-1323
University of Washington
25-Jul-2004


Page: 1 2

Related biology news :

1. Targeted therapy knocks out pediatric brain cancer in mice
2. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
3. Columbia research to examine gene influence on severity of peridontal disease, therapy response
4. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
5. The search for a kinder, gentler chemotherapy
6. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
7. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
8. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
9. Jefferson Lab detector technology aids development of cystic fibrosis therapy
10. Stroking up cellular therapy
11. Smart gene therapy protects against damage from heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2019)... ... December 03, 2019 , ... ... and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, ... Inc. (“Ethicann”), a Calgary-based pharmaceutical company using botanically sourced cannabinoid oils to ...
(Date:11/27/2019)... ... ... Though the forecast for the Thanksgiving holiday might look a bit grim, there’s ... roads and the skies. It’s a new personal recipe organizer app called MINE Recipes. ... design, mouth-watering pictures of food, an optional social component and an easy-to-navigate recipe manager. ...
(Date:11/22/2019)... ... November 21, 2019 , ... The inventors of ... have announced a major step forward with that therapy, known as SurVaxM. MimiVax ... company, spun off from Roswell Park in 2012, has entered into a China-exclusive ...
Breaking Biology News(10 mins):
(Date:1/8/2020)... ... January 08, 2020 , ... Anomet ... achieve specific properties for use in harsh environments inside or outside of the ... to three metals or alloys to achieve specific properties such as corrosion-resistance, biocompatibility, ...
(Date:1/7/2020)... Kingdom (PRWEB) , ... January 07, 2020 , ... ... recombinant antibody products and services, today announced the launch of its VivopureX™ recombinant ... popular antibody clones, many originally obtained from rats or hamsters, which Absolute Antibody ...
(Date:1/7/2020)... Mass. (PRWEB) , ... January 06, 2020 , ... ... for a Digital World at The Fletcher School at Tufts University, is pleased ... Sloan Foundation. The grant will be administered by Tufts University, and will help ...
(Date:1/7/2020)... ... January 06, 2020 , ... ABCT , the Accelerator ... invited to participate in the annual program. Twelve ventures will participate in the ... professional network. All startups will receive an entrepreneur coach, access to active business ...
Breaking Biology Technology:
Cached News: